FDAnews
www.fdanews.com/articles/202761-becton-dickinsons-self-collection-hpv-test-receives-ce-mark
CE mark

Becton Dickinson’s Self-Collection HPV Test Receives CE Mark

May 14, 2021

Becton Dickinson has received CE mark certification for its Onclarity HPV Assay, a human papillomavirus test that can also help screen for cervical cancer.

Using the assay, women can collect vaginal samples at home and send them to a laboratory for processing on the company’s Viper LT or COR systems.

The assay identifies 14 high-risk forms of HPV in a single analysis and provides genotyping information from specimens for use in cervical cancer screening.

View today's stories